Related references
Note: Only part of the references are listed.The ROS-NOX Connection in Cancer and Angiogenesis
Christophe Blanchetot et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Apurinic/Apyrimidinic Endonuclease/Redox Effector Factor-1(APE/Ref-1): A Unique Target for the Prevention and Treatment of Human Melanoma
Sun Yang et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase
Jennifer D. Tibodeau et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
Meghan B. Azad et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)
Farnaz Zahedi Avval et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation
Nukhet Aykin-Burns et al.
BIOCHEMICAL JOURNAL (2009)
Catalase and glutathione peroxidase mimics
Brian J. Day
BIOCHEMICAL PHARMACOLOGY (2009)
Pharmacology of a mimetic of glutathione disulfide, NOV-002
Danyelle M. Townsend et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer
Dawn P. G. Brown et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide
Steve Oh et al.
CANCER LETTERS (2009)
NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-MCell Cycle Progression
Maki Yamaura et al.
CANCER RESEARCH (2009)
The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells
V. Ashutosh Rao et al.
CANCER RESEARCH (2009)
Tumor Protein 53-Induced Nucear Protein 1 Is a Major Mediator of p53 Antioxidant Function
Carla E. Cano et al.
CANCER RESEARCH (2009)
The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth
Christopher M. Cabello et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling
G. Kallifatidis et al.
GUT (2009)
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
J. E. Chang et al.
HEMATOLOGICAL ONCOLOGY (2009)
MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL
Minesh P. Mehta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Biochemical Mechanism of Acetaminophen (APAP) Induced Toxicity in Melanoma Cell Lines
Nikhil M. Vad et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Mitochondria as targets for cancer therapy
Stephen J. Ralph et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Vitamin E analogues as mitochondria-targeting compounds: From the bench to the bedside?
Yan Zhao et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Targeting Hypoxia-inducible Factor-1α With Tf-PEI-shRNA Complex via Transferrin Receptor-mediated Endocytosis Inhibits Melanoma Growth
Yeqiang Liu et al.
MOLECULAR THERAPY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective
Antonio Lavecchia et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Alfonso Quintas-Cardama et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: From molecular redox mechanisms to health implications
Margret S. Rodrigues et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: Small-molecule inhibition of the redox function of Ape1
Meihua Luo et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Redox regulation of cell survival
Dunyaporn Trachootham et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
The development of HKI-272 and related compounds for the treatment of cancer
Allan Wissner et al.
ARCHIV DER PHARMAZIE (2008)
Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines
Sharon Rozenblat et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Glutaredoxin systems
Christopher Horst Lillig et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors
Allen A. Thomas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Possible chemical mechanisms underlying the antitumor activity of S-deoxyleinamycin
Santhosh Sivaramakrishnan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Inhibition of thioredoxin reductase by curcumin analogs
Zhong Liu et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Zinc protoporphyrin IX, a heme oxygenase-I inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
Dominika Nowis et al.
BMC CANCER (2008)
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
F. Donate et al.
BRITISH JOURNAL OF CANCER (2008)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer
S. L. C. Tagg et al.
BRITISH JOURNAL OF CANCER (2008)
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
M. E. Callister et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The thioredoxin system: a key target in tumour and endothelial cells
A. Mukherjee et al.
BRITISH JOURNAL OF RADIOLOGY (2008)
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Hagop Kantarjian et al.
CANCER (2008)
Imaging of tumor glucose utilization with positron emission tomography
Andrea Buerkle et al.
CANCER AND METASTASIS REVIEWS (2008)
Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects
Gregory A. Reed et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Multi-targeted prevention of cancer by sulforaphane
John D. Clarke et al.
CANCER LETTERS (2008)
Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs
Stephen Safe et al.
CANCER LETTERS (2008)
Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds
Anna A. Powolny et al.
CANCER LETTERS (2008)
Optimized Clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104
Shie-Chau Liu et al.
CANCER RESEARCH (2008)
NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance
Danyelle M. Townsend et al.
CANCER RESEARCH (2008)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Anju Singh et al.
CANCER RESEARCH (2008)
Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives
Yayoi Fukuyo et al.
CANCER RESEARCH (2008)
1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase
Ping Lei et al.
CARCINOGENESIS (2008)
Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells
Takashi Hosono et al.
CARCINOGENESIS (2008)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells
Xin Mao et al.
CELL RESEARCH (2008)
Identification, synthesis, and enzymology of non-natural glucosinolate chemopreventive candidates
Jared R. Mays et al.
CHEMBIOCHEM (2008)
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells
Wan Seok Yang et al.
CHEMISTRY & BIOLOGY (2008)
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
David B. Solit et al.
CLINICAL CANCER RESEARCH (2008)
Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
Sarah A. Lowndes et al.
CLINICAL CANCER RESEARCH (2008)
A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies
Kyriakos P. Papadopoulos et al.
CLINICAL CANCER RESEARCH (2008)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: Phase II study results
Robert J. Amato et al.
CLINICAL GENITOURINARY CANCER (2008)
In Vitro Screening Techniques for Reactive Metabolites for Minimizing Bioactivation Potential in Drug Discovery
Chandra Prakash et al.
CURRENT DRUG METABOLISM (2008)
Synthetic small molecule Cdc25 phosphatases inhibitors
Laura Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Mitochondrial drugs
Peter L. Toogood
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Chemosensitization of cancer by nitric oxide
Richard Sullivan et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth
Melissa L. Fishel et al.
DNA REPAIR (2008)
Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia
Roberto Stasi
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Reactive oxygen species: an Achilles' heel of melanoma?
John P. Fruehauf et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity
Eng-Hui Chew et al.
FASEB JOURNAL (2008)
New uses for old drugs.: Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro:: Mechanistic and pharmacological implications
Anna Rosa Sannella et al.
FEBS LETTERS (2008)
Alpha-Tocopheryl succinate: Toxicity and lack of anti-tumour activity in immuno-competent mice
Demelza J. Ireland et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Cancer chemoprevention:: A radical perspective
Numsen Hail et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress
Georg T. Wondrak et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated
Kristin K. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells
Sanjeewani T. Palayoor et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Ikuhiko Nakase et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Structure-activity relationships for hepatocyte toxicity and electrophilic reactivity of α,β-unsaturated esters, acrylates and methacrylates
Katie Chan et al.
JOURNAL OF APPLIED TOXICOLOGY (2008)
Mitochondrial voltage-dependent anion channels (VDACs) as novel pharmacological targets for anti-cancer agents
Eriko Simamura et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2008)
Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells
Ji Su Kim et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2008)
Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells
Dong Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Covalent binding to tubulin by isothiocyanates - A mechanism of cell growth arrest and apoptosis
Lixin Mi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tricyclic [1,2,4]Triazine 1,4-Dioxides As Hypoxia Selective Cytotoxins
Michael P. Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane Antimalarials
Igor Opsenica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: A biodistribution and survival study
Mustafa Vali et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence
Maryam M. Asgari et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer
Giuseppe Filomeni et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms
Sharmila Shankar et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Elesclomol induces cancer cell apoptosis through oxidative stress
Jessica R. Kirshner et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Mitochondria-Dependent Reactive Oxygen Species-Mediated Programmed Cell Death Induced by 3,3′-Diindolylmethane through Inhibition of F0F1-ATP Synthase in Unicellular Protozoan Parasite Leishmania donovani
Amit Roy et al.
MOLECULAR PHARMACOLOGY (2008)
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism
H. Zhang et al.
LEUKEMIA (2008)
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines
Z. Diaz et al.
LEUKEMIA (2008)
Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases
Timothy E. Bael et al.
MELANOMA RESEARCH (2008)
Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines
Nikhil M. Vad et al.
MELANOMA RESEARCH (2008)
The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
D. A. Frohlich et al.
ONCOGENE (2008)
α-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II
L-F Dong et al.
ONCOGENE (2008)
Commentary: Novel therapies for cancer: Why dirty might be better
Tito Fojo
ONCOLOGIST (2008)
The reactive oxygen-driven tumor: relevance to melanoma
Levi Fried et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Role of Reactive Oxygen Intermediates in Cellular Responses to Dietary Cancer Chemoprevention Agents
Jedrzej Antosiewicz et al.
PLANTA MEDICA (2008)
Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1 alpha-induced gene in pancreatic cancer
Amanda F. Baker et al.
PANCREAS (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells
Benoit Boivin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Further insights into the mechanism of the reaction of activated bleomycin with DNA
Marina S. Chow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth
Markus Ralser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
Jose C. Juarez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glucose sensing by MondoA:Mlx complexes:: A role for hexokinases and direct regulation of thioredoxin-interacting protein expression
Carrie A. Stoltzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Jennifer S. Fang et al.
SEMINARS IN CANCER BIOLOGY (2008)
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Brigette Ma et al.
INVESTIGATIONAL NEW DRUGS (2008)
7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one(Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined Immunodeficient mouse transplant model
Narasimharao Bhagavathula et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Triethylene tetramine, a novel ligand of G-quadruplex, induces senescence of MCF-7 cells
Guo Lixia et al.
BIOTECHNOLOGY LETTERS (2008)
Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands
Paul V. Bernhardt et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines
A. Mukherjee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: The influence of hydrogen bond donors on extravascular transport and antitumor activity
Michael P. Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Modulation of reactive oxygen species in pancreatic cancer
Melissa L. T. Teoh et al.
CLINICAL CANCER RESEARCH (2007)
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
Monica L. Guzman et al.
BLOOD (2007)
Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1.: Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity
Karen A. Nolan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium
M. J. Mackenzie et al.
INVESTIGATIONAL NEW DRUGS (2007)
Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species
Yongqiang Chen et al.
JOURNAL OF CELL SCIENCE (2007)
Novel agents for cancer prevention based on nitric oxide
B. Rigas
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation
Metin Kurtoglu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Role of NADPH cytochrome P450 reductase in activation of RH1
Asher Begleiter et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II
Anna Kawiak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells
Arabinda Das et al.
CANCER (2007)
Apoptosis induction of 2′-hydroxycinnamaldehyde as a proteasorne inhibitor is associated with ER stress and mitochondrial perturbation in cancer cells
Su Hyung Hong et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells
Song Zhang et al.
CANCER LETTERS (2007)
Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system
Hee Shim Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Thioredoxin signaling as a target for cancer therapy
Garth Powis et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage
Se-Yeong Oh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Isoobtusilactone a induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells
Po-Lin Kuo et al.
CANCER RESEARCH (2007)
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol
Masato Kato et al.
STRUCTURE (2007)
Peroxide bond-dependent antiplasmodial specificity of arternisinin and OZ277 (RBx11160)
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
HIF2α reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma
Judith Favier et al.
BMC CANCER (2007)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis
Georg T. Wondrak
FREE RADICAL BIOLOGY AND MEDICINE (2007)
The mechanism of action of nitric oxide-donating aspirin
Khosrow Kashfi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-κB1 DNA binding domain
Cherie Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-κB
Daizo Oka et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho
Masahiro Shinohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels
Nicholas Yagoda et al.
NATURE (2007)
The antitumor agent imexon activates antioxidant gene expression: Evidence for an oxidative stress response
Amanda F. Baker et al.
CLINICAL CANCER RESEARCH (2007)
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1α activation in C6 glioma cells
Xiao-Jia Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
被撤回的出版物: NRH:Quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53 (Retracted article. See vol. 75, pg. 615, 2015)
Xing Gong et al.
CANCER RESEARCH (2007)
Collateral damage in cancer chemotherapy - Oxidative stress in nontargeted tissues
Yumin Chen et al.
MOLECULAR INTERVENTIONS (2007)
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1):: NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells
Philip Reigan et al.
BIOCHEMISTRY (2007)
Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability
Pavel B. Kopnin et al.
CANCER RESEARCH (2007)
Vitamin E analogs, a novel group of mitocans, as anticancer agents: The importance of being redox-silent
Jiri Neuzil et al.
MOLECULAR PHARMACOLOGY (2007)
Future of toxicology-iron chelators and differing modes of action and toxicity: The changing face of iron chelation therapy
Danuta S. Kalinowski et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Phase I trial of imexon in patients with advanced malignancy
Tomislav Dragovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Novel action of paclitaxel against cancer cells: Bystander effect mediated by reactive oxygen species
Jerome Alexandre et al.
CANCER RESEARCH (2007)
Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling
Lisa J. Frederiksen et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Christine Marzano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress
Crescent R. Isham et al.
BLOOD (2007)
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma
James R. Berenson et al.
CLINICAL CANCER RESEARCH (2007)
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
Baskaran Govindarajan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Opinion - Why is cancer drug discovery so difficult?
Alexander Kamb et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Superoxide dismutase as a target enzyme for Fe-porphyrin-induced cell death
Shoichiro Asayama et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Reactive oxygen species: A breath of life or death?
John P. Fruehauf et al.
CLINICAL CANCER RESEARCH (2007)
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
Anna Berkenblit et al.
CLINICAL CANCER RESEARCH (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA
Maria Berndtsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer
T. E. Roche et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Willmar Schwabe Award 2006: Antiplasmodial and antitumor activity of arternisinin - From bench to bedside
Thomas Efferth
PLANTA MEDICA (2007)
2-Deoxy-D-glucose combined with cisplatin, enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells
Andreart L. Simons et al.
CANCER RESEARCH (2007)
Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex
Dimitrios J. Stravopodis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Glycolysis in cancer: A potential target for therapy
Robert A. Gatenby et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
Pentose phosphate cycle oxidative and nonoxidative balance:: A new vulnerable target for overcoming drug resistance in cancer
Antonio Ramos-Montoya et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells
Juan Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
Li Hua Wang et al.
CANCER CELL (2006)
Motexafin gadolinium: A novel redox active drug for cancer therapy
Darren Magda et al.
SEMINARS IN CANCER BIOLOGY (2006)
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing hypoxic tumor cells
Theodore J. Lampidis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Bioenergetics and the formation of mitochondrial reactive oxygen species
Vera Adam-Vizi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice
Alan Pourpak et al.
ANTI-CANCER DRUGS (2006)
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype
Linda Holmquist-Mengelbier et al.
CANCER CELL (2006)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Protein disulfide isomerase expression is related to the invasive properties of malignant glioma
Dorota Goplen et al.
CANCER RESEARCH (2006)
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Glutathione peroxidases and redox-regulated transcription factors
Regina Brigelius-Flohe
BIOLOGICAL CHEMISTRY (2006)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L. Tatum et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer
Anju Singh et al.
PLOS MEDICINE (2006)
Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice
Betsy N. Perry et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H: quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins
Wenchang Guo et al.
MOLECULAR PHARMACOLOGY (2006)
Oxidative inhibition of receptor-type protein-tyrosine phosphatase κ by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes
Yiru Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant
Nuri Gueven et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice
Julien Verrax et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs
Kevin O. Hicks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1
Jose C. Juarez et al.
CLINICAL CANCER RESEARCH (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
S. P. Mathupala et al.
ONCOGENE (2006)
Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth
Christine J. Weydert et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Mateusz Koptyra et al.
BLOOD (2006)
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo
Jerome Alexandre et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl] indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo
Donna L. Dehn et al.
MOLECULAR CANCER THERAPEUTICS (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway
Akira Yoshida et al.
CANCER RESEARCH (2006)
PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo
Siddhartha Kar et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol
Gad Asher et al.
BIOCHEMISTRY (2006)
Thioredoxin reductase as a novel molecular target for cancer therapy
Phuongmai Nguyen et al.
CANCER LETTERS (2006)
Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3′-indolyl)methane (DIM) and 5,5′-dibromoDIM
Kathy Vanderlaag et al.
CANCER LETTERS (2006)
c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells
Jedrzej Antosiewicz et al.
CANCER RESEARCH (2006)
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: Docking of ligands and enzymatic inhibition mechanism
Antonio Lavecchia et al.
CHEMMEDCHEM (2006)
Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes
Nannette Jelluma et al.
MOLECULAR CANCER RESEARCH (2006)
3,3′-diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21Cip1/Waf1 expression by induction of oxidative stress in human breast cancer cells
Yixuan Gong et al.
CANCER RESEARCH (2006)
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase
SI Hashemy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
RK Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy
M Marty et al.
ANNALS OF ONCOLOGY (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors thioredoxin reductase
G Powis et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway
JS Finch et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir
J Alexandre et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
JE Saavedra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
AF Baker et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5
H Kim et al.
CANCER RESEARCH (2006)
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat
H Lai et al.
CANCER LETTERS (2006)
Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-α and chemotherapy
M Benlloch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The redox regulation of thiol dependent signaling pathways in cancer
Gregory I. Giles
CURRENT PHARMACEUTICAL DESIGN (2006)
A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms
Claus Jacob
NATURAL PRODUCT REPORTS (2006)
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Y. Liu
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection
GT Wondrak et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2006)
The redox regulation of PI 3-kinase-dependent signaling
Nick R. Leslie
ANTIOXIDANTS & REDOX SIGNALING (2006)
Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase
Kathryn M. Johnson et al.
ACS CHEMICAL BIOLOGY (2006)
Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of β-tubulin
T Hosono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells
RH Xu et al.
LEUKEMIA (2005)
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor
S Yang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
The antioxidant function of the p53 tumor suppressor
AA Sablina et al.
NATURE MEDICINE (2005)
Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy
C Kirszberg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
F Hong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo
GL Disbrow et al.
CANCER RESEARCH (2005)
Mechanisms of therapy-related carcinogenesis
JM Allan et al.
NATURE REVIEWS CANCER (2005)
Population aging and cancer: A cross-national concern
R Yancik
CANCER JOURNAL (2005)
Mitochondrial tumour suppressors: A genetic and biochemical update
E Gottlieb et al.
NATURE REVIEWS CANCER (2005)
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Q Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Resistance to paclitaxel is proportional to cellular total antioxidant capacity
B Ramanathan et al.
CANCER RESEARCH (2005)
Generation of reactive oxygen species by a persultide (BnSSH)
T Chatterji et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor KB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway
DR Siwak et al.
CANCER (2005)
Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin
EM Hoke et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Activation of c-Jun-N-terminal kinase is required for apoptosis triggered by glutathione disulfide in neuroblastoma cells
G Filomeni et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Regulation of the cell cycle in response to inhibition of mitochondrial generated energy
A Gemin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model
L Xu et al.
CANCER RESEARCH (2005)
Thioredoxin reductase is irreversibly modified by curcumin - A novel molecular mechanism for its anticancer activity
JG Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PKC sulfhydryl targeting by disulfiram produces divergent isozymic regulatory responses that accord with the cancer preventive activity of the thiuram disulfide
F Chu et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: An anticancer agent targeting hypoxic cells
HA Seow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer
CJ Sweeney et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Elucidation of thioredoxin as a molecular target for antitumor quinols
TD Bradshaw et al.
CANCER RESEARCH (2005)
Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines
D Magda et al.
CANCER RESEARCH (2005)
A novel benzodiazepine selectively inhibits keratinocyte proliferation and reduces retinoid-induced epidermal hyperplasia in organ-cultured human skin
J Varani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423
KM Johnson et al.
CHEMISTRY & BIOLOGY (2005)
Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice
S Suy et al.
CANCER (2005)
Induction of apoptosis by curcumin and its implications for cancer therapy
D Karunagaran et al.
CURRENT CANCER DRUG TARGETS (2005)
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
BK Adams et al.
ANTI-CANCER DRUGS (2005)
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity
HR Tsou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Mitochondrial O2-• and H2O2 mediate glucose deprivation-induced cytotoxicity and oxidative stress in human cancer cells
IM Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
T Efferth
DRUG RESISTANCE UPDATES (2005)
Quinols as novel therapeutic agents. 2. 4-(1-arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents
JM Berry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Multifunctional redox catalysts as selective enhancers of oxidative stress
FH Fry et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Isolation of a small molecule inhibitor of DNA base excision repair
S Madhusudan et al.
NUCLEIC ACIDS RESEARCH (2005)
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
VJ Findlay et al.
MOLECULAR PHARMACOLOGY (2004)
Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line
T Tarumoto et al.
EXPERIMENTAL HEMATOLOGY (2004)
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin
J Fang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide
YH Zheng et al.
ONCOGENE (2004)
Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy
ES Nyman et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2004)
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity
EJ Meuillet et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides
JP Lau et al.
BRITISH JOURNAL OF CANCER (2004)
Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells
EC Vaquero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
DZ Cen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
DT-diaphorase: a target for new anticancer drugs
S Danson et al.
CANCER TREATMENT REVIEWS (2004)
Synthetic peroxides as antimalarials
YQ Tang et al.
MEDICINAL RESEARCH REVIEWS (2004)
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine
H Maeda et al.
CELL DEATH AND DIFFERENTIATION (2004)
Treatment of pancreatic cancer cells with Dicumarol induces cytotoxicity and oxidative stress
A Lewis et al.
CLINICAL CANCER RESEARCH (2004)
Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor
LH Wang et al.
NATURE MEDICINE (2004)
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Chemical basis for the biological activity of imexon and related cyanoaziridines
BS Iyengar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Directed biosynthesis of fluorinated pseurotin A, synerazol and gliotoxin
Y Igarashi et al.
JOURNAL OF ANTIBIOTICS (2004)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Crystal structure of γ-glutamylcysteine synthetase:: Insights into the mechanism of catalysis by a key enzyme for glutathione homeostasis
T Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation
J Mitsushita et al.
CANCER RESEARCH (2004)
NAD(P)H:quinone oxidoreductase 1:: Role as a superoxide scavenger
D Siegel et al.
MOLECULAR PHARMACOLOGY (2004)
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
R Clarke et al.
ONCOGENE (2003)
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
NR Leslie et al.
EMBO JOURNAL (2003)
Superoxide dismutase 1 knock-down induces senescence in human fibroblasts
G Blander et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of mitochondrial respiration - A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism
H Pelicano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects
WE Samlowski et al.
NATURE MEDICINE (2003)
Small molecules that mimic the thiol-triggered alkylating properties seen in the natural product leinamycin
T Chatterji et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
KI Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase
HW Jeong et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma
JD Wolchok et al.
MELANOMA RESEARCH (2003)
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
S Dolma et al.
CANCER CELL (2003)
Chemogenomic identification of Ref-l/AP-1 as a therapeutic target for asthma
C Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model
ML Schito et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Redox catalysts as sensitisers towards oxidative stress
NM Giles et al.
FEBS LETTERS (2003)
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
A Wissner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 mitogen-activated protein kinase pathway
G Filomeni et al.
FASEB JOURNAL (2002)
Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: Scavenging of reactive oxygen species versus induction of heme oxygenase-1
EA Konorev et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Cysteine-modifying agents: A possible approach for effective anticancer and antiviral drugs
A Casini et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2002)
Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies
SR Doctrow et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Influx of calcium through a redox-sensitive plasma membrane channel in thymocytes causes early necrotic cell death induced by the epipolythiodioxopiperazine toxins
AM Hurne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vitamin E succinate inhibits colon cancer liver metastases
KT Barnett et al.
JOURNAL OF SURGICAL RESEARCH (2002)
The iron metabolism of neoplastic cells: alterations that facilitate proliferation?
JC Kwok et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Characterization of a mechanism-based inhibitor of NAD(P)H: Quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches
SL Winski et al.
BIOCHEMISTRY (2001)
Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53
JA Bush et al.
EXPERIMENTAL CELL RESEARCH (2001)
Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones
AJ García-Piñeres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
On the origin of cytotoxicity of the natural product varacin. A novel example of a pentathiepin reaction that provides evidence for a triatomic sulfur intermediate
A Greer
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
2-Methoxyestradiol does not inhibit superoxide dismutase
R Kachadourian et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Oxidation of zinc finger transcription factors: Physiological consequences
KA Webster et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase
BHB Kwok et al.
CHEMISTRY & BIOLOGY (2001)
Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells
JM Grad et al.
BLOOD (2001)
Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia
P Wardman
CURRENT MEDICINAL CHEMISTRY (2001)
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
FQ Schafer et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Redox regulation in human melanocytes and melanoma
FL Meyskens et al.
PIGMENT CELL RESEARCH (2001)
Induction of mitochondrial changes in myeloma cells by imexon
K Dvorakova et al.
BLOOD (2001)
Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents
NA Pham et al.
EXPERIMENTAL CELL RESEARCH (2001)
Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides
W Beerheide et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Superoxide dismutase as a target for the selective killing of cancer cells
P Huang et al.
NATURE (2000)
Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon
K Dvorakova et al.
BIOCHEMICAL PHARMACOLOGY (2000)
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
M Sattler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
